Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Role for interferon-gamma in rat strains with different susceptibility to experimental autoimmune myasthenia gravis.

Clinical immunology (Orlando, Fla.) - 1 May 2000

Wang H B, Shi F D, Li H, van der Meide P H, Ljunggren H G, Link H

Abstract excerpt

Experimental autoimmune myasthenia gravis (EAMG) is caused by autoantibodies against the nicotinic acetylcholine receptor (AChR) at the neuromuscular postsynaptic membrane and represents an animal model of myasthenia gravis in human. Recent studies highlighted the roles of TH1 cytokines (IFN-gamma, IL-12), rather than TH2 cytokines (IL-4), in the pathogenesis of EAMG by using homozygous (-/-) knockout mice with...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies
Share to Disease Susceptibility

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Immunoglobulin Isotypes

Share to Interferon-gamma

Share to Lymphocyte Activation

Share to Rats, Inbred Lew

Share to Receptors, Cholinergic

Share to Transforming Growth Factor beta

Source

Identifiers

PMID: 10779409
DOI: 10.1006/clim.2000.4850

Genes

TNF

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Role for interferon-gamma in rat strains with different susceptibility to experimental autoimmune myasthenia gravis.PMID 10779409Read ↗

Mice with IFN-gamma receptor deficiency are less susceptible to experimental autoimmune myasthenia gravis.Semantic proximity Read ↗

Experimental autoimmune myasthenia gravis may occur in the context of a polarized Th1- or Th2-type immune response in rats.Semantic proximity Read ↗

C57BL/6 mice genetically deficient in IL-12/IL-23 and IFN-gamma are susceptible to experimental autoimmune myasthenia gravis, suggesting a pathogenic role of non-Th1 cells.Semantic proximity Read ↗

Absence of IFN-gamma or IL-12 has different effects on experimental myasthenia gravis in C57BL/6 mice.Semantic proximity Read ↗

Myocyte production of nitric oxide in response to AChR-reactive antibodies in two inbred rat strains may influence disease outcome in experimental myasthenia gravis.Semantic proximity Read ↗

Transgenic expression of IL-10 in T cells facilitates development of experimental myasthenia gravis.Semantic proximity Read ↗

Tumor necrosis factor receptor p55 and p75 deficiency protects mice from developing experimental autoimmune myasthenia gravis.Semantic proximity Read ↗

Absence of IL-4 facilitates the development of chronic autoimmune myasthenia gravis in C57BL/6 mice.Semantic proximity Read ↗

Major histocompatibility complex class II gene disruption prevents experimental autoimmune myasthenia gravis.Semantic proximity Read ↗

Genetic deficiency of estrogen receptor alpha fails to influence experimental autoimmune myasthenia gravis pathogenesis.Semantic proximity Read ↗

MHC and non-MHC gene regulation of disease susceptibility and disease course in experimental inflammatory peripheral neuropathy.Semantic proximity Read ↗

Direct Proof of the In Vivo Pathogenic Role of the AChR Autoantibodies from Myasthenia Gravis PatientsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.